CD19 and hemophilia A: To this end, we first adapted our fluorescent-FVIII-based flow cytometric staining protocol for FVIII-specific CD19+ B cells to the human system, aiming to sort such B cells from healthy volunteers or hemophilia A patients for analytical comparison.